A review on the monoacylglycerol lipase: At the interface between fat and endocannabinoid signalling

Current Medicinal Chemistry

Volumn 17, Issue 24, 2010, Pages 2588-2607

  Labar, G ^a,b   Wouters, J ^b   Lambert, D M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF NAMUR   (Belgium)

Author keywords

2 Arachidonoylglycerol; Endocannabinoid system; Inhibitor; Monoacylglycerol lipase; Monoglyceride lipase

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 CHLOROMERCURIBENZOIC ACID; ACYLGLYCEROL LIPASE; ANANDAMIDE; CANNABINOID RECEPTOR; CAY 10499; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYSTEINE; DISULFIRAM; ENDOCANNABINOID; ESTERASE INHIBITOR; HORMONE SENSITIVE LIPASE; JZL 184; LY 2183240; MELOXICAM; MONOGLYCERIDE LIPASE INHIBITOR; N ARACHIDONYLMALEIMIDE; N ETHYLMALEIMIDE; OMDM 169; RIMONABANT; SAR 629; SPB 01403; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; URB 602;

ADIPOSE TISSUE; ARTICLE; CANCER RESEARCH; CARCINOGENESIS; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; INFLAMMATION; LIPID TRANSPORT; MOLECULAR DOCKING; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PAIN; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

ANIMALS; ENDOCANNABINOIDS; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL; MONOACYLGLYCEROL LIPASES; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 77955614363     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791859414     Document Type: Article

References (118)

1. Russo, E. B. History of cannabis and its preparations in saga, science, and sobriquet. Chem. Biodivers., 2007, 4, 1614-48.
2. Gaoni, Y.; Mechoulam, R. Isolation, structure and partial synthesis of an active constituant of hashish. J. Am. Chem. Soc., 1964, 86, 1646-7.
3. Mechoulam, R.; Feigenbaum, J. J. Towards cannabinoid drugs. Prog. Med. Chem., 1987, 24, 159-207.
4. Little, P. J.; Compton, D. R.; Johnson, M. R.; Melvin, L. S.; Martin, B. R. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmacol. Exp. Ther., 1988, 247, 1046-51.
5. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990, 346, 561-4.
6. Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365, 61-5.
7. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 1992, 258, 1946-9.
8. Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 1995, 215, 89-97.
9. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N. E.; Schatz, A. R.; Gopher, A.; Almog, S.; Martin, B. R.; Compton, D. R. Identification of an endogenous 2- monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 1995, 50, 83-90.
10. Di Marzo, V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol. Res., 2009, 60, 77-84.
11. Di Marzo, V; Petrosino, S. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol., 2007, 18, 129-40.
12. Howlett, A. C. Cannabinoid receptor signaling. Handb. Exp. Pharmacol., 2005, 53-79.
13. Kano, M.; Ohno-Shosaku, T.; Hashimotodani, Y.; Uchigashima, M.; Watanabe, M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev., 2009, 89, 309-80.
14. Pacher, P.; Batkai, S.; Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 2006, 58, 389-462.
15. Liu, J.; Wang, L.; Harvey-White, J.; Huang, B. X.; Kim, H. Y.; Luquet, S.; Palmiter, R. D.; Krystal, G.; Rai, R.; Mahadevan, A.; Razdan, R. K.; Kunos, G. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology, 2008, 54, 1-7.
16. Sugiura, T.; Kishimoto, S.; Oka, S.; Gokoh, M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res., 2006, 45, 405-46.
17. Wang, J.; Ueda, N. Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat., 2009, 89, 112-9.
18. De Petrocellis, L.; Di Marzo, V. An introduction to the endocannabinoid system: from the early to the latest concepts. Best. Pract. Res. Clin. Endocrinol. Metab, 2009, 23, 1-15.
19. Cravatt, B. F.; Giang, D. K.; Mayfield, S. P.; Boger, D. L.; Lerner, R. A.; Gilula, N. B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 1996, 384, 83-7.
20. Cravatt, B. F.; Demarest, K.; Patricelli, M. P.; Bracey, M. H.; Giang, D. K.; Martin, B. R.; Lichtman, A. H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U.S.A., 2001, 98, 9371-6.
21. Lafontan, M.; Langin, D. Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res., 2009, 48, 275-97.
22. Vaughan, M.; Berger, J. E.; Steinberg, D. Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue. J. Biol. Chem., 1964, 239, 401-9.
23. Fredrikson, G.; Stralfors, P.; Nilsson, N. O.; Belfrage, P. Hormonesensitive lipase of rat adipose tissue. Purification and some properties. J. Biol. Chem., 1981, 256, 6311-20.
24. Zechner, R.; Kienesberger, P. C.; Haemmerle, G.; Zimmermann, R.; Lass, A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res., 2009, 50, 3-21.
25. Fredrikson, G.; Belfrage, P. Positional specificity of hormonesensitive lipase from rat adipose tissue. J. Biol. Chem., 1983, 258, 14253-6.
26. Fredrikson, G.; Tornqvist, H.; Belfrage, P. Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochim. Biophys. Acta, 1986, 876, 288-93.
27. Berglund, L.; Khoo, J. C.; Jensen, D.; Steinberg, D. Resolution of hormone-sensitive triglyceride/diglyceride lipase from monoglyceride lipase of chicken adipose tissue. J. Biol. Chem., 1980, 255, 5420-8.
28. Stralfors, P.; Belfrage, P. Phosphorylation of hormone-sensitive lipase by cyclic AMP-dependent protein kinase. J. Biol. Chem., 1983, 258, 15146-52.
29. Belfrage, P.; Fredrikson, G.; Nilsson, N. O.; Stralfors, P. Regulation of adipose tissue lipolysis: phosphorylation of hormones sensitive lipase in intact rat adipocytes. FEBS Lett., 1980, 111, 120-4.
30. Nilsson, N. O.; Stralfors, P.; Fredrikson, G.; Belfrage, P. Regulation of adipose tissue lipolysis: effects of noradrenaline and insulin on phosphorylation of hormone-sensitive lipase and on lipolysis in intact rat adipocytes. FEBS Lett., 1980, 111, 125-30.
31. Osuga, J.; Ishibashi, S.; Oka, T.; Yagyu, H.; Tozawa, R.; Fujimoto, A.; Shionoiri, F.; Yahagi, N.; Kraemer, F. B.; Tsutsumi, O.; Yamada, N. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl. Acad. Sci. U.S.A., 2000, 97, 787-92.
32. Haemmerle, G.; Zimmermann, R.; Hayn, M.; Theussl, C.; Waeg, G.; Wagner, E.; Sattler, W.; Magin, T. M.; Wagner, E. F.; Zechner, R. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J. Biol. Chem., 2002, 277, 4806-15.
33. Wang, S. P.; Laurin, N.; Himms-Hagen, J.; Rudnicki, M. A.; Levy, E.; Robert, M. F.; Pan, L.; Oligny, L.; Mitchell, G. A. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes. Res., 2001, 9, 119-28.
34. Zimmermann, R.; Strauss, J. G.; Haemmerle, G.; Schoiswohl, G.; Birner-Gruenberger, R.; Riederer, M.; Lass, A.; Neuberger, G.; Eisenhaber, F.; Hermetter, A.; Zechner, R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science, 2004, 306, 1383-6.
35. Haemmerle, G.; Lass, A.; Zimmermann, R.; Gorkiewicz, G.; Meyer, C.; Rozman, J.; Heldmaier, G.; Maier, R.; Theussl, C.; Eder, S.; Kratky, D.; Wagner, E. F.; Klingenspor, M.; Hoefler, G.; Zechner, R. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science, 2006, 312, 734-7.
36. Festuccia, W. T.; Laplante, M.; Berthiaume, M.; Gelinas, Y.; Deshaies, Y. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia, 2006, 49, 2427-36.
37. Kershaw, E. E.; Schupp, M.; Guan, H. P.; Gardner, N. P.; Lazar, M. A.; Flier, J. S. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab., 2007, 293, E1736-E1745.
38. Subramanian, V.; Rothenberg, A.; Gomez, C.; Cohen, A. W.; Garcia, A.; Bhattacharyya, S.; Shapiro, L.; Dolios, G.; Wang, R.; Lisanti, M. P.; Brasaemle, D. L. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J. Biol. Chem., 2004, 279, 42062-71.
39. Yamaguchi, T.; Omatsu, N.; Matsushita, S.; Osumi, T. CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome. J. Biol. Chem., 2004, 279, 30490-7.
40. Granneman, J. G.; Moore, H. P.; Granneman, R. L.; Greenberg, A. S.; Obin, M. S.; Zhu, Z. Analysis of lipolytic protein trafficking and interactions in adipocytes. J. Biol. Chem., 2007, 282, 5726-35.
41. Granneman, J. G.; Moore, H. P.; Krishnamoorthy, R.; Rathod, M. Perilipin controls lipolysis by regulating the interactions of abhydrolase containing 5 (Abhd5) and adipose trigylceride lipase (ATGL). J. Biol. Chem., 2009.
42. Zimmermann, R.; Lass, A.; Haemmerle, G.; Zechner, R. Fate of fat: the role of adipose triglyceride lipase in lipolysis. Biochim. Biophys. Acta, 2009, 1791, 494-500.
43. Kupiecki, F. P. Partial purification of monoglyceride lipase from adipose tissue. J. Lipid Res., 1966, 7, 230-5.
44. Tornqvist, H.; Belfrage, P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem., 1976, 251, 813-9.
45. Karlsson, M.; Contreras, J. A.; Hellman, U.; Tornqvist, H.; Holm, C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem., 1997, 272, 27218-23.
46. Karlsson, M.; Reue, K.; Xia, Y. R.; Lusis, A. J.; Langin, D.; Tornqvist, H.; Holm, C. Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene, 2001, 272, 11-8.
47. Wall, E. M.; Cao, J.; Chen, N.; Buller, R. M.; Upton, C. A novel poxvirus gene and its human homolog are similar to an E. coli lysophospholipase. Virus Res., 1997, 52, 157-67.
48. Arpigny, J. L.; Jaeger, K. E. Bacterial lipolytic enzymes: classification and properties. Biochem. J., 1999, 343 Pt 1, 177-83.
49. Ollis, D. L.; Cheah, E.; Cygler, M.; Dijkstra, B.; Frolow, F.; Franken, S. M.; Harel, M.; Remington, S. J.; Silman, I.; Schrag, J.;. The alpha/beta hydrolase fold. Protein Eng., 1992, 5, 197-211.
50. Karlsson, M.; Tornqvist, H.; Holm, C. Expression, purification, and characterization of histidine-tagged mouse monoglyceride lipase from baculovirus-infected insect cells. Protein Expr. Purif., 2000, 18, 286-92.
51. Vila, A.; Rosengarth, A.; Piomelli, D.; Cravatt, B.; Marnett, L. J. Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase. Biochemistry, 2007, 46, 9578-85.
52. Rindlisbacher, B.; Reist, M.; Zahler, P. Diacylglycerol breakdown in plasma membranes of bovine chromaffin cells is a two-step mechanism mediated by a diacylglycerol lipase and a monoacylglycerol lipase. Biochim. Biophys. Acta, 1987, 905, 349- 57.
53. Vandevoorde, S.; Saha, B.; Mahadevan, A.; Razdan, R. K.; Pertwee, R. G.; Martin, B. R.; Fowler, C. J. Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. Biochem. Biophys. Res. Commun., 2005, 337, 104-9.
54. Ghafouri, N.; Tiger, G.; Razdan, R. K.; Mahadevan, A.; Pertwee, R. G.; Martin, B. R.; Fowler, C. J. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2- arachidonoylglycerol. Br. J. Pharmacol., 2004, 143, 774-84.
55. Dinh, T. P.; Carpenter, D.; Leslie, F. M.; Freund, T. F.; Katona, I.; Sensi, S. L.; Kathuria, S.; Piomelli, D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U. S. A, 2002, 99, 10819-24.
56. Gulyas, A. I.; Cravatt, B. F.; Bracey, M. H.; Dinh, T. P.; Piomelli, D.; Boscia, F.; Freund, T. F. Segregation of two endocannabinoidhydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur. J. Neurosci., 2004, 20, 441-58.
57. Blankman, J. L.; Simon, G. M.; Cravatt, B. F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2- arachidonoylglycerol. Chem. Biol., 2007, 14, 1347-56.
58. Dinh, T. P.; Kathuria, S.; Piomelli, D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol. Pharmacol., 2004, 66, 1260-4.
59. Saario, S. M.; Salo, O. M.; Nevalainen, T.; Poso, A.; Laitinen, J. T.; Jarvinen, T.; Niemi, R. Characterization of the sulfhydrylsensitive site in the enzyme responsible for hydrolysis of 2- arachidonoyl-glycerol in rat cerebellar membranes. Chem. Biol., 2005, 12, 649-56.
60. Vandevoorde, S.; Jonsson, K. O.; Labar, G.; Persson, E.; Lambert, D. M.; Fowler, C. J. Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. Br. J. Pharmacol., 2007, 150, 186-91.
61. Long, J. Z.; Li, W.; Booker, L.; Burston, J. J.; Kinsey, S. G.; Schlosburg, J. E.; Pavon, F. J.; Serrano, A. M.; Selley, D. E.; Parsons, L. H.; Lichtman, A. H.; Cravatt, B. F. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol., 2009, 5, 37-44.
62. Long, J. Z.; Nomura, D. K.; Cravatt, B. F. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem. Biol., 2009, 16, 744-53.
63. Rakhshandehroo, M.; Sanderson, L. M.; Matilainen, M.; Stienstra, R.; Carlberg, C.; de Groot, P. J.; Muller, M.; Kersten, S. Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR. Res., 2007, 2007, 26839.
64. Di Marzo, V. CB(1) receptor antagonism: biological basis for metabolic effects. Drug Discov. Today, 2008, 13, 1026-41.
65. Patel, S.; Carrier, E. J.; Ho, W. S.; Rademacher, D. J.; Cunningham, S.; Reddy, D. S.; Falck, J. R.; Cravatt, B. F.; Hillard, C. J. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J. Lipid Res., 2005, 46, 342-9.
66. Kathuria, S.; Gaetani, S.; Fegley, D.; Valino, F.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; La, R. G.; Calignano, A.; Giustino, A.; Tattoli, M.; Palmery, M.; Cuomo, V.; Piomelli, D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med., 2003, 9, 76-81.
67. Fegley, D.; Gaetani, S.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; Piomelli, D. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J. Pharmacol. Exp. Ther., 2005, 313, 352-8.
68. Stella, N.; Piomelli, D. Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur. J. Pharmacol., 2001, 425, 189-96.
69. Wilson, R. I.; Nicoll, R. A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature, 2001, 410, 588-92.
70. Hohmann, A. G.; Suplita, R. L.; Bolton, N. M.; Neely, M. H.; Fegley, D.; Mangieri, R.; Krey, J. F.; Walker, J. M.; Holmes, P. V.; Crystal, J. D.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; Piomelli, D. An endocannabinoid mechanism for stress-induced analgesia. Nature, 2005, 435, 1108-12.
71. Makara, J. K.; Mor, M.; Fegley, D.; Szabo, S. I.; Kathuria, S.; Astarita, G.; Duranti, A.; Tontini, A.; Tarzia, G.; Rivara, S.; Freund, T. F.; Piomelli, D. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat. Neurosci., 2005, 8, 1139-41.
72. Kim, J.; Alger, B. E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci., 2004, 7, 697-8.
73. Hashimotodani, Y.; Ohno-Shosaku, T.; Kano, M. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J. Neurosci., 2007, 27, 1211-9.
74. Pan, B.; Wang, W.; Long, J. Z.; Sun, D.; Hillard, C. J.; Cravatt, B. F.; Liu, Q. S. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4- (dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1- carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. J. Pharmacol. Exp. Ther., 2009, 331, 591-7.
75. Straiker, A.; Hu, S. S.; Long, J. Z.; Arnold, A.; Wager-Miller, J.; Cravatt, B. F.; Mackie, K. Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol. Pharmacol., 2009, 76, 1220-7.
76. Chevaleyre, V.; Castillo, P. E. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron, 2003, 38, 461-72.
77. Safo, P. K.; Regehr, W. G. Endocannabinoids control the induction of cerebellar LTD. Neuron, 2005, 48, 647-59.
78. Hashimotodani, Y.; Ohno-Shosaku, T.; Kano, M. Endocannabinoids and synaptic function in the CNS. Neuroscientist, 2007, 13, 127-37.
79. Nomura, D. K.; Long, J. Z.; Niessen, S.; Hoover, H. S.; Ng, S. W.; Cravatt, B. F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell, 2010, 140, 49-61.
80. Zvonok, N.; Pandarinathan, L.; Williams, J.; Johnston, M.; Karageorgos, I.; Janero, D. R.; Krishnan, S. C.; Makriyannis, A. Covalent inhibitors of human monoacylglycerol lipase: ligandassisted characterization of the catalytic site by mass spectrometry and mutational analysis. Chem. Biol., 2008, 15, 854-62.
81. Matuszak, N.; Muccioli, G. G.; Labar, G.; Lambert, D. M. Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J. Med. Chem., 2009, 52, 7410-20.
82. Burston, J. J.; Sim-Selley, L. J.; Harloe, J. P.; Mahadevan, A.; Razdan, R. K.; Selley, D. E.; Wiley, J. L. N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase. J. Pharmacol. Exp. Ther., 2008, 327, 546-53.
83. Labar, G.; Bauvois, C.; Muccioli, G. G.; Wouters, J.; Lambert, D. M. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling. Chembiochem., 2007, 8, 1293-7.
84. Kapanda, C. N.; Muccioli, G. G.; Labar, G.; Poupaert, J. H.; Lambert, D. M. Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors. J. Med. Chem., 2009, 52, 7310-4.
85. King, A. R.; Lodola, A.; Carmi, C.; Fu, J.; Mor, M.; Piomelli, D. A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. Br. J. Pharmacol., 2009, 157, 974-83.
86. King, A. R.; Dotsey, E. Y.; Lodola, A.; Jung, K. M.; Ghomian, A.; Qiu, Y.; Fu, J.; Mor, M.; Piomelli, D. Discovery of potent and reversible monoacylglycerol lipase inhibitors. Chem. Biol., 2009, 16, 1045-52.
87. Nithipatikom, K.; Endsley, M. P.; Isbell, M. A.; Falck, J. R.; Iwamoto, Y.; Hillard, C. J.; Campbell, W. B. 2- arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res., 2004, 64, 8826-30.
88. Nithipatikom, K.; Endsley, M. P.; Isbell, M. A.; Wheelock, C. E.; Hammock, B. D.; Campbell, W. B. A new class of inhibitors of 2- arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. Biochem. Biophys. Res. Commun., 2005, 332, 1028-33.
89. Boger, D. L.; Sato, H.; Lerner, A. E.; Austin, B. J.; Patterson, J. E.; Patricelli, M. P.; Cravatt, B. F. Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition. Bioorg. Med. Chem. Lett., 1999, 9, 265-70.
90. Moore, S. A.; Nomikos, G. G.; Dickason-Chesterfield, A. K.; Schober, D. A.; Schaus, J. M.; Ying, B. P.; Xu, Y. C.; Phebus, L.; Simmons, R. M.; Li, D.; Iyengar, S.; Felder, C. C. Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc. Natl. Acad. Sci. U.S.A., 2005, 102, 17852-7.
91. Alexander, J. P.; Cravatt, B. F. The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J. Am. Chem. Soc., 2006, 128, 9699-704.
92. Maione, S.; Morera, E.; Marabese, I.; Ligresti, A.; Luongo, L.; Ortar, G.; Di Marzo, V. Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and noncannabinoid receptor-mediated mechanisms. Br. J. Pharmacol., 2008, 155, 775-82.
93. Ortar, G.; Cascio, M. G.; Moriello, A. S.; Camalli, M.; Morera, E.; Nalli, M.; Di Marzo, V. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. Eur. J. Med. Chem., 2008, 43, 62-72.
94. Even; Hoornaert. Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof. WO 2008/145839, PCT/FR2008/000532., 2008.
95. Even; Hoornaert. Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof. WO 2008/145843, PCT/FR2008/000536, 2008.
96. Hoornaert. Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof. WO 2008/145842, PCT/FR2008/000535, 2008.
97. Bisogno, T.; Ortar, G.; Petrosino, S.; Morera, E.; Palazzo, E.; Nalli, M.; Maione, S.; Di Marzo, V. Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. Biochim. Biophys. Acta, 2009, 1791, 53-60.
98. Labar, G.; Michaux, C. Fatty acid amide hydrolase: from characterization to therapeutics. Chem. Biodivers., 2007, 4, 1882- 902.
99. King, A. R.; Duranti, A.; Tontini, A.; Rivara, S.; Rosengarth, A.; Clapper, J. R.; Astarita, G.; Geaga, J. A.; Luecke, H.; Mor, M.; Tarzia, G.; Piomelli, D. URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem. Biol., 2007, 14, 1357-65.
100. Comelli, F.; Giagnoni, G.; Bettoni, I.; Colleoni, M.; Costa, B. The inhibition of monoacylglycerol lipase by URB602 showed an antiinflammatory and anti-nociceptive effect in a murine model of acute inflammation. Br. J. Pharmacol., 2007, 152, 787-94.
101. Saario, S. M.; Poso, A.; Juvonen, R. O.; Jarvinen, T.; Salo-Ahen, O. M. Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. J. Med. Chem., 2006, 49, 4650-6.
102. Muccioli, G. G.; Labar, G.; Lambert, D. M. CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay. Chembiochem, 2008, 9, 2704-10.
103. Minkkila, A.; Savinainen, J. R.; Kasnanen, H.; Xhaard, H.; Nevalainen, T.; Laitinen, J. T.; Poso, A.; Leppanen, J.; Saario, S. M. Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors. ChemMedChem, 2009, 4, 1253-9.
104. Li, W.; Blankman, J. L.; Cravatt, B. F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J. Am. Chem. Soc., 2007, 129, 9594-5.
105. Bowman, A. L.; Makriyannis, A. Refined homology model of monoacylglycerol lipase: toward a selective inhibitor. J. Comput. Aided Mol. Des, 2009, 23, 799-806.
106. Zvonok, N.; Williams, J.; Johnston, M.; Pandarinathan, L.; Janero, D. R.; Li, J.; Krishnan, S. C.; Makriyannis, A. Full mass spectrometric characterization of human monoacylglycerol lipase generated by large-scale expression and single-step purification. J. Proteome. Res., 2008, 7, 2158-64.
107. Labar, G.; Bauvois, C.; Borel, F.; Ferrer, J. L.; Wouters, J.; Lambert, D. M. Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling. Chembiochem, 2010, 11, 218-27.
108. Bertrand, T.; Auge, F.; Houtmann, J.; Rak, A.; Vallee, F.; Mikol, V.; Berne, P. F.; Michot, N.; Cheuret, D.; Hoornaert, C.; Mathieu, M. Structural basis for human monoglyceride lipase inhibition. J. Mol. Biol., 2010, 396, 663-73.
109. Hofmann, B.; Tolzer, S.; Pelletier, I.; Altenbuchner, J.; van Pee, K. H.; Hecht, H. J. Structural investigation of the cofactor-free chloroperoxidases. J. Mol. Biol., 1998, 279, 889-900.
110. Cheeseman, J. D.; Tocilj, A.; Park, S.; Schrag, J. D.; Kazlauskas, R. J. Structure of an aryl esterase from Pseudomonas fluorescens. Acta Crystallogr. D. Biol. Crystallogr., 2004, 60, 1237-43.
111. Elmi, F.; Lee, H. T.; Huang, J. Y.; Hsieh, Y. C.; Wang, Y. L.; Chen, Y. J.; Shaw, S. Y.; Chen, C. J. Stereoselective esterase from Pseudomonas putida IFO12996 reveals alpha/beta hydrolase folds for D-beta-acetylthioisobutyric acid synthesis. J. Bacteriol., 2005, 187, 8470-6.
112. Line, K.; Isupov, M. N.; Littlechild, J. A. The crystal structure of a (-) gamma-lactamase from an Aureobacterium species reveals a tetrahedral intermediate in the active site. J. Mol. Biol., 2004, 338, 519-32.
113. Kaneko, T.; Tanaka, N.; Kumasaka, T. Crystal structures of RsbQ, a stress-response regulator in Bacillus subtilis. Protein Sci., 2005, 14, 558-65.
114. Roussel, A.; Miled, N.; Berti-Dupuis, L.; Riviere, M.; Spinelli, S.; Berna, P.; Gruber, V.; Verger, R.; Cambillau, C. Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor. J. Biol. Chem., 2002, 277, 2266-74.
115. Brzozowski, A. M.; Derewenda, U.; Derewenda, Z. S.; Dodson, G. G.; Lawson, D. M.; Turkenburg, J. P.; Bjorkling, F.; Huge-Jensen, B.; Patkar, S. A.; Thim, L. A model for interfacial activation in lipases from the structure of a fungal lipase-inhibitor complex. Nature, 1991, 351, 491-4.
116. Egloff, M. P.; Marguet, F.; Buono, G.; Verger, R.; Cambillau, C.; van Tilbeurgh, H. The 2.46 A resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. Biochemistry, 1995, 34, 2751-62.
117. van Tilbeurgh, H.; Gargouri, Y.; Dezan, C.; Egloff, M. P.; Nesa, M. P.; Ruganie, N.; Sarda, L.; Verger, R.; Cambillau, C. Crystallization of pancreatic procolipase and of its complex with pancreatic lipase. J. Mol. Biol., 1993, 229, 552-4.
118. Eydoux, C.; Spinelli, S.; Davis, T. L.; Walker, J. R.; Seitova, A.; Dhe-Paganon, S.; De Caro, A.; Cambillau, C.; Carriere, F. Structure of human pancreatic lipase-related protein 2 with the lid in an open conformation. Biochemistry, 2008, 47, 9553-64.